ACHV Q3 2024 Earnings — Achieve Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

ACHVAchieve Life Sciences, Inc.

$233M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$12M

Net Income

-$13M

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$48M

Total Liabilities

$17M

Stockholders' Equity

$31M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$100,000	+100.0%
Operating Income	-$12M	-$7M	-89.7%
Net Income	-$13M	-$7M	-76.0%